Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Italy's Bracco Taps Korea To Boost Sales Of Medical Contrast Mediums; Takes On Bayer Schering And GE Healthcare

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Italy's Bracco has opened a Korean unit as part of its efforts to increase share for its medical contrast mediums in a market already dominated by Bayer Schering Pharma and GE Healthcare

You may also be interested in...



EstechPharma In Talks With German Company For MRI Contrast Medium Agents; Korean API Makers Struggle For Global Foothold

SEOUL - South Korea's active pharmaceutical ingredient company EstechPharma is currently in talks with a German-based multinational company, likely Bayer Schering Pharma, to sell its two generic MRI contrast medium products

EstechPharma In Talks With German Company For MRI Contrast Medium Agents; Korean API Makers Struggle For Global Foothold

SEOUL - South Korea's active pharmaceutical ingredient company EstechPharma is currently in talks with a German-based multinational company, likely Bayer Schering Pharma, to sell its two generic MRI contrast medium products

GE Healthcare Set To Launch First Global Ubiquitous Health R&D Center In Korea

SEOUL - Aiming to gain momentum from South Korea's push to enhance the national healthcare industry, GE Healthcare is gearing up to open its first global ubiquitous health research and development center in Asia

UsernamePublicRestriction

Register

LL1132440

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel